Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001451612-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 24, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
17,800
Total Value
$624,941.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 5,641 | $14.18 | $79,989.38 | 5,641 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 259 | $20.00 | $5,180.00 | 5,900 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 22, 2026 | Sale | 5,900 | $89.96 | $530,764.00 | 0 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 22, 2026 | Sale | 88 | $90.08 | $7,927.04 | 3,899,829 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Apr 22, 2026 | Sale | 12 | $90.08 | $1,080.96 | 674,944 | Indirect | See footnote | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 5,641 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 259 | $0.00 | $0.00 | 39,868 | Direct | โ | View Details |